These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3006449)

  • 1. Converting enzyme inhibition in mild and moderate essential hypertension. II.
    Rasmussen S; Leth A; Ibsen H; Damkjaer Nielsen M; Nielsen F; Giese J
    Acta Med Scand; 1986; 219(1):29-36. PubMed ID: 3006449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Converting enzyme inhibition in mild and moderate essential hypertension. I. Acute effects on blood pressure, the renin-angiotensin system and blood bradykinin after a single dose of captopril.
    Rasmussen S; Leth A; Ibsen H; Damkjaer Nielsen M; Nielsen F; Giese J
    Acta Med Scand; 1985; 218(5):435-42. PubMed ID: 3004113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Captopril in mild and moderate essential hypertension: physiological and biochemical monitoring.
    Rasmussen S; Leth A; Ibsen H; Damkjaer Nielsen M; Nielsen F; Giese J
    Acta Med Scand Suppl; 1983; 677():105-9. PubMed ID: 6322529
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
    Iimura O; Shimamoto K
    Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive peptides and hypertension: role of angiotensin converting enzyme.
    Johnston CI; Iansek R; Millar JA; McGrath BP; Matthews PG
    Aust N Z J Med; 1981; 11(Suppl 1):59-63. PubMed ID: 6266379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Converting enzyme activity in regulation of blood pressure and kidney function. A review.
    Piryova B; Girchev R
    Cor Vasa; 1984; 26(6):401-7. PubMed ID: 6098419
    [No Abstract]   [Full Text] [Related]  

  • 8. The renin-angiotensin system during converting enzyme inhibition with captopril in patients with severe treatment-resistant hypertension.
    Rasmussen S; Damkjaer Nielsen M; Ibsen H; Leth A; Giese J
    Eur J Clin Invest; 1984 Feb; 14(1):30-6. PubMed ID: 6321195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension.
    Johnston CI; Millar JA; McGrath BP; Matthews PG
    Lancet; 1979 Sep; 2(8141):493-6. PubMed ID: 90216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antihypertensive mechanism of oral angiotensin I converting enzyme inhibitor (captopril) in renin-independent essential hypertension].
    Miyamori I; Takeda Y; Ikeda M; Koshida H; Yasuhara S; Morise T; Takimoto H; Takeda R; Nishino T
    Nihon Naibunpi Gakkai Zasshi; 1983 Jun; 59(6):907-17. PubMed ID: 6311635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
    Shepherd AN; Campbell BC; Reid JL
    J Cardiovasc Pharmacol; 1982; 4(3):381-7. PubMed ID: 6177933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal changes with long-term converting-enzyme inhibition by captopril in essential hypertension.
    Matthews PG; McGrath BP; Johnston CI
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():135s-138s. PubMed ID: 232017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
    Kiowski W; Linder L; Kleinbloesem C; van Brummelen P; Bühler FR
    Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of alterations of the renin-angiotensin system and the sympathetic nervous system on plasma bradykinin concentration in patients with essential hypertension].
    Takeda Y
    Nihon Naibunpi Gakkai Zasshi; 1984 Sep; 60(9):1112-24. PubMed ID: 6097486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of captopril on blood pressure and circulating hormone levels in salt-replete and depleted normal subjects and essential hypertensive patients.
    Millar JA; McGrath BP; Matthews PG; Johnston CI
    Clin Sci (Lond); 1981 Jul; 61(1):75-83. PubMed ID: 7018813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal responses to long-term converting enzyme inhibition in hypertensive patients.
    Ogihara T; Maruyama A; Hata T; Mikami H; Nakamaru M; Naka T; Ohde H; Kumahara Y
    Clin Pharmacol Ther; 1981 Sep; 30(3):328-35. PubMed ID: 6268347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of hydrochlorothiazide on various components of the kinin system and plasma renin activity in patients with arterial hypertension treated with captopril].
    Kolber-Postepska B; Zebrowska-Lupina I; Markiewicz M; Horubała-Bielak G
    Wiad Lek; 1992 Aug; 45(15-16):569-74. PubMed ID: 1336910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Responses of plasma bradykinin and the renin angiotensin axis to angiotensin II in hyperthyroid patients].
    Takeda Y; Miyamori I; Ikeda M; Koshida H; Yasuhara S; Morise T; Okamoto S; Kawato M; Takeda R
    Nihon Naibunpi Gakkai Zasshi; 1986 Feb; 62(2):61-8. PubMed ID: 3009241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.